SAN ANTONIO--(BUSINESS WIRE)--Chris H. M. Takimoto, M.D., Ph.D., an internationally recognized leader in the development of new anti-cancer drugs, has been named director of pharmacology at South Texas Accelerated Research Therapeutics (START). Dr. Takimoto comes to START from the Cancer Therapy & Research Center’s Institute for Drug Development, where he was pharmacology director and held the Zachry Chair of Translational Research.
